NCT07211126View on ClinicalTrials.gov

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

Not yet recruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Diabetes Mellitus, Type 1

Interventions

DEVICE

t:slim X2 insulin pump with Control-IQ technology (Control-IQ System)

Participants enrolled in the study will start use of the t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) with Dexcom G6 or Dexcom G7, and be followed for 12 months.

All Listed Sponsors

lead

Tandem Diabetes Care, Inc.

INDUSTRY